Affinity Asset Advisors’s Enliven Therapeutics ELVN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.02M Buy
+400,000
New +$8.02M 1.1% 25